As cases of uterine cancer rise, a new non-invasive test being studied in clinical trials at @columbiamed.bsky.social could offer a simpler, more comfortable way to diagnose the disease and help some women avoid an invasive biopsy. Here's what to know: www.cancer.columbia.edu/news/new-swa...

New Swab Test for Endometrial Cancer Could Offer Easier Diagnosis

A non-invasive test being studied in clinical trials at Columbia and 11 other medical centers may soon offer a simpler, more comfortable way to diagnose endometrial (uterine) cancer.

cancer.columbia.edu

Happening today at 4:57 PM CDT: Results from NEXUS-01, a phase 1 study of LY4052031 from Alexander Wei, MD will be discussed in an Oral Abstract Session on Genitourinary Cancer—Kidney and Bladder. Read the abstract - asco.org/abstracts-pr...

Abstract now live! Research from Columbia author Catherine Shu, MD will be presented in an Oral Abstract on Lung Cancer—Non-Small Cell Metastatic. View more- asco.org/abstracts-pr...

We are headed to #ASCO26! ✈️🔬Follow along with us May 29 - June 2 as we share HICCC research being presented at ASCO's annual meeting! @columbiamed.bsky.social

Breakthroughs in cancer research don’t usually begin with multi-million-dollar grants — they start with one bold idea. See how pilot funding has helped HICCC researchers take risks to shape the future of cancer treatments. #NationalCancerResearchMonth www.cancer.columbia.edu/news/idea-im...

From Idea to Impact: How Pilot Funding Fuels Cancer Discovery

Early-stage, strategic investments help researchers test bold ideas, creating momentum and new directions in cancer research.

cancer.columbia.edu

Great write-up from @columbiacancer.bsky.social "A cellular wrong turn in blood cancer” on our paper from @cohesinlab.bsky.social published in @bloodjournal.bsky.social . 🔑Key point: STAG2 doesn’t change how much GATA1 there is—it changes where it can act. www.cancer.columbia.edu/news/cellula...

A cellular wrong turn in blood cancer

A new study reveals how disrupted DNA navigation leads to impaired red blood cell development in myelodysplastic syndrome

cancer.columbia.edu

Super proud of my postdoc, Alvaro Curiel-Garcia @alvarocuriel.bsky.social for his Rising Star lecture at #AACR26. Alvaro has a Nature Genetics cofirst author paper in press, and another 1st author manuscript that is in revision, also at Nature Genetics. He's on the job market folks!

Millions of women are finding out they have dense breasts, but what to do next still leaves many uncertain. In this Q&A, Julia McGuinness & Elena Elkin explain why breast density alone isn’t enough to guide breast cancer screening decisions: www.cancer.columbia.edu/news/beyond-...

HICCC is AACR-bound! ✈️🔬 Take a look at our @theaacr.bsky.social 2026 roundup and mark your calendar: our research will be shared in 40+ sessions and presentations. Check out our major symposia highlights from this year’s meeting, below: www.cancer.columbia.edu/news/roundup...

Roundup: HICCC at AACR 2026

HICCC researchers will present updates across key cancer research topics at this year's American Association for Cancer Research annual meeting.

cancer.columbia.edu

Julia McGuinness, MD has been awarded a $100,000 @preventcancer.org grant to study whether weight-loss treatments lead to mammogram changes that signal lower breast cancer risk. 👏 Learn more. preventcancer.org/news/prevent...

Prevent Cancer Foundation@preventcancer.org · 6mo ago

We are proud to announce that we’ve awarded nearly $1 million in new research grants for nine scientists advancing cancer prevention and early detection education, innovation, health equity, and more. 🧵1/4

Big changes to U.S. nutrition guidance are here with the HHS new “inverted” food pyramid. For Cancer Prevention Month, @columbiamed.bsky.social dietitian Sabrina Oliver breaks down how to view the guidelines through a cancer-prevention lens. 🥦🥩 www.cancer.columbia.edu/news/does-ne...

Does the New Food Pyramid Match What We Know About Cancer Prevention?

Oncology dietician Sabrina Oliver reflects on the new “inverted” food pyramid and how people can interpret the guidelines through a cancer-prevention lens.

cancer.columbia.edu

‼️After a decade+ of research, @columbiamed.bsky.social scientists led by Wei Gu have discovered the natural mechanism behind a novel form of cell death called ferroptosis. Read about this work in @cellpress.bsky.social www.cancer.columbia.edu/news/ironing...

Ironing Out Cancer

Columbia researchers have discovered the natural mechanism behind a type of cell death called ferroptosis - solving a longstanding puzzle in cell biology.

cancer.columbia.edu

New research led by Andrea Califano, Dr, unveils a framework to decode hundreds of thousands of previously “uninterpretable” cancer mutations— helping clinicians prioritize more effective treatments and avoid unnecessary ones. @biohub.org 🔗 www.cancer.columbia.edu/news/turning...

Sarcoma is rare, but inequities in life-saving care are widespread in underserved communities. Read how Wakenda Tyler, MD, is pushing the field to confront disparities, like higher amputation and mortality rates. #BlackHistoryMonth @columbiamed.bsky.social www.cancer.columbia.edu/news/wakenda...

Wakenda Tyler, MD: Bringing Health Equity into Sarcoma Care

In honor of Black History Month, we spoke with Dr. Tyler about why she thinks disparities research should be a priority in sarcoma care.

cancer.columbia.edu

💭 Do GLP-1s raise, lower, or not affect cancer risk? As GLP-1 drugs surge in popularity, so have questions about their safety, especially around cancer. Based on current evidence, the answer is reassuring and increasingly hopeful. ⤵️ www.cancer.columbia.edu/news/glp-1-w...

GLP-1 Weight Loss Drugs and Cancer: Is There a Link?

GLP-1 weight-loss medications have changed how doctors treat obesity- here’s what we know about their impact on cancer.

cancer.columbia.edu

A national clinical trial open at @columbiamed.bsky.social is testing a new precision medicine approach developed by Rob Wechsler-Reya, PhD- directly testing how each patient’s tumor cells respond to different drugs, rather than testing genetics alone. → www.cancer.columbia.edu/news/q-testi...

Testing Drug Responses, Not Just Genes: A New Functional Precision Medicine Trial Comes to Columbia

We spoke with Rob Wechsler-Reya, PhD, about a novel functional precision medicine approach that he developed, which is being tested in a national clinical trial now opening at Columbia.

cancer.columbia.edu

The 2025 issue of Pathways to a Cure is here! See how HICCC is driving breakthroughs in cell therapy, AI precision prevention, and early-onset cancers—while expanding access to world-class care at Columbia. Read now ⬇️ pubs.cancer.columbia.edu/reports/2025...

2025 Annual Report

The Herbert Irving Comprehensive Cancer Center earned renewed Comprehensive Cancer Center designation from the National Cancer Institute for 2025–2030, with $27 million in funding to strengthen cancer...

pubs.cancer.columbia.edu

Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma - @columbiacancer.bsky.social go.nature.com/496Ins7

HICCC is presenting at #ASH2025! Follow along for highlights on research from Columbia at this year’s American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando. ↘️Be sure to tag us to be promoted! View more: mailchi.mp/cumc/hiccc-w...

The first FDA-approved liquid biopsy test for cancer screening is here - and raising big questions about how it could transform cancer care. HICCC’s Dr. Chin Hur weighs in. More in this Q&A 👉 cancer.columbia.edu/news/what-kn...

What to Know About Liquid Biopsies for Cancer

Liquid biopsies have the potential to transform cancer care. We asked Dr. Chin Hur how these tests fit into the future of personalized cancer screening, now that one has FDA approval.

cancer.columbia.edu

The Spring/Summer issue of Accelerations is here! We're spotlighting momentum— discover what's next in cancer research, breakthroughs in drug discovery, and progress in pancreatic cancer. Read the issue below. hiccc-accelerations.onpubli.com/Spring-Summe...

Getting through the blood-brain barrier remains a huge challenge in brain tumor treatment. Read how HICCC researchers Elisa Konofagou & Stergios Zacharoulis are using #soundwaves to open it just long enough to deliver therapy. engineering.columbia.edu/about/news/t...

Uterine cancer is one of the few cancers with rising incidence and mortality. A new @columbiamed.bsky.social study led by HICCC’s Jason D. Wright projects a sharp increase over the next 30 years—disproportionately impacting Black women. Read more: www.cuimc.columbia.edu/news/uterine...

Uterine Cancer Rates Predicted to Rise, Especially Among Black Women

A new study forecasts a substantial rise in uterine cancer cases and deaths over the next three decades, with a disproportionate impact on Black women.

cuimc.columbia.edu

Last week, we celebrated the official launch of the Center for Innovation in Imaging Biomarkers and Integrated Diagnostics (CIMBID) at Columbia. @columbiamed.bsky.social Catch the highlights and recordings below. @columbiaimaging.bsky.social columbiaradiology.org/news/columbi...

Today marks Day 1 of the second cohort of the 2025 IICD Intensive Workshop. We’re thrilled to welcome a new group of graduate students and postdocs for a week of immersive learning! #CancerResearch #STEMeducation @elhamazizi.bsky.social @columbiamed.bsky.social @columbiacancer.bsky.social

Tattoos last forever-but do they come with health risks that stick around just as long? 💭 HICCC's Dr. Mariam El-Ashmawy breaks down what early research shows —and what you can do to protect your skin with or without tattoos. www.cancer.columbia.edu/news/tattoos...

Tattoos and Skin Cancer: A Cause for Concern?

Mariam El-Ashmawy, MD, PhD, shares what you need to know about tattoos and skin cancer—and how to protect your skin for the long run.

cancer.columbia.edu

The SRP interns had a great seminar with Dr. @brentstockwell.bsky.social Thank you, Dr. Stockwell, for sharing your career path and research with our summer interns! 🔬✨ #CancerResearch #STEMeducation #IICDSR #SummerInternship @columbiacancer.bsky.social

Highlights from HICCC's 3rd Annual Clinical Trials Day at @columbiamed.bsky.social 🏥👏 Thank you to everyone who joined us last week to learn about the urgent need for broader participation in #ClinicalTrials

View today's final HICCC #ASCO2025 daily roundup, below!

View today's HICCC #ASCO2025 daily roundup, below!